We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas (NOA-16)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02454634
Recruitment Status : Completed
First Posted : May 27, 2015
Last Update Posted : November 7, 2018
University Hospital Heidelberg
German Cancer Research Center
Neuro-Oncology Working Group of the German Cancer Society
Information provided by (Responsible Party):
National Center for Tumor Diseases, Heidelberg